🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
98 participants will be randomly assigned 1:1 to the experimental group and...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2024-12-20
Trial ID
NCT06703398
Treatments Being Tested
This is a multicenter, randomized, open-label, Phase 3 study...
Status
Recruiting
Location
Beijing Oncology Hospital
Start Date
2023-10-25
Trial ID
NCT06008119
This study is a single cohort, open label exploratory clinical trial aimed ...
Status
Recruiting
Location
Tianjin Medical Unversity Second Hospital
Start Date
2027-08-31
Trial ID
NCT07170293
Treatments Being Tested
This study is a prospective, open-label, single-arm clinical trial evaluati...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-20
Trial ID
NCT07302841
Treatments Being Tested
This study investigated the efficacy and safety of Tunlametinib Combination...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-15
Trial ID
NCT07463677
Treatments Being Tested
Efficacy of Tunlametinib in Combination With Anti-EGFR Monoclonal Antibody ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-03
Trial ID
NCT07446270
This is a multicenter, two-arm, open-label, randomized controlled phase III...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2023-11-02
Trial ID
NCT06008106
Treatments Being Tested
This study is a prospective, open-label, multicenter, real-world clinical s...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2026-01-28
Trial ID
NCT07445022
Treatments Being Tested
This study investigated the efficacy and safety of Tunlametinib Combination...
Status
Not Yet Recruiting
Location
Sun Yat-sen University
Start Date
2026-11-30
Trial ID
NCT07714447
The goal of this clinical trial is to learn if the combination of disitamab...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-04
Trial ID
NCT07507526
Treatments Being Tested